Fetal dose during radiotherapy: Clinical implementation and review of the literature
Cancer/Radiotherapie , Volume 6 - Issue 6 p. 352- 357
Two pregnant patients received radiation therapy, one for the treatment of mediastinal Hodgkin's lymphoma and the other for a head and neck squamous cell carcinoma. The fetuses were both protected by additional shielding which reduced the unshielded exposure of the first fetus by 20-40%, and that of the second by 20-60%. The first child received an estimated maximum dose of 42 cGy, the second a maximum dose of 9 cGy. Treatment details are reported and a review of the literature that addresses the possible irradiation-induced side effects at low doses is included.
|Organisation||Department of Radiation Oncology|
Nuyttens, J.J.M.E, Prado, F, Jenrette, J.M, & Williams, T.E. (2002). Fetal dose during radiotherapy: Clinical implementation and review of the literature. Cancer/Radiotherapie, 6(6), 352–357. doi:10.1016/S1278-3218(02)00249-4